Mannkind, Game-Chancer in Sachen Diabetik? (Seite 576)
eröffnet am 11.01.11 13:02:26 von
neuester Beitrag 08.05.24 23:29:18 von
neuester Beitrag 08.05.24 23:29:18 von
Beiträge: 6.835
ID: 1.162.683
ID: 1.162.683
Aufrufe heute: 38
Gesamt: 594.205
Gesamt: 594.205
Aktive User: 0
ISIN: US56400P7069 · WKN: A2DMZL · Symbol: MNKD
4,4000
USD
-1,57 %
-0,0700 USD
Letzter Kurs 02:00:00 Nasdaq
Neuigkeiten
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 2,4000 | +49,07 | |
| 4,0500 | +26,96 | |
| 1,7600 | +25,53 | |
| 1,6500 | +22,22 | |
| 23,950 | +21,08 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,7100 | -20,11 | |
| 13,610 | -20,92 | |
| 7,5000 | -28,30 | |
| 2,2900 | -28,88 | |
| 0,7494 | -32,49 |
Beitrag zu dieser Diskussion schreiben
Feedback
Nein, nein, hier die meiner Meinung nach richtige Meinung aus dem Yahoo-Board, kann ich nur zustimmen:
Let's make this one clear
.
There are (have been) five major (binary) events:
1. Phase III results Affinity Trial
2. Adcom Panel
3. Approval
4. Partnership
5. Market Acceptance
If you look deeper to this events, you must realize, that the events 1, 2 and 3 could not have been influenced by Mannkind (although Mannkinds presentation at the adcom was brilliant).
A negtaive outcome one of these events would have send MNKD near zero!
This factor is completly out now! Mannkind has won this war!
Shorties: No reason any longer to place a stop loss order, because the situation since friday has completly changed. MNKD has now everything under complete control. Not only $40 Mill coming from Deerfield - even a secondary offering would not create much dilution and gives Mannkind more power in negotiations - I can not see any pressure from outside - so we are to decide partnership. Acceptance of Afrezza has already been proved through 6.500 Patients in clinical trials - only very few Patients discontinued trial as a result institutional buying will begin now very heavily before the train has left the station.
Fact: 68 Mill shares are short (30% of float), although many of them are hedged with call options
Fact: 47 % shares owned by Insiders
Fact: 18 % shares held by Institutions
We can be sure that due to institutional interest pps driving higher, makes outstanding float much lower. We can also be sure that shorts will attack pps on monday again (picking all stop loss orders). I think, we will see an ugly monday with very, very nervous trading and several attacks.
But one thing is sure: pps will definitly drive much, much higher in the coming days, weeks, month and years!
No more possible event, which could hinder Afrezza's triumph!! Technosphere ? I'm so glad to own this stock! I will never sell shares in double digits other than a buyout - and both events are very soon possible!
regards
Kimi Less
. .
.
Back To Board
Let's make this one clear
.
There are (have been) five major (binary) events:
1. Phase III results Affinity Trial
2. Adcom Panel
3. Approval
4. Partnership
5. Market Acceptance
If you look deeper to this events, you must realize, that the events 1, 2 and 3 could not have been influenced by Mannkind (although Mannkinds presentation at the adcom was brilliant).
A negtaive outcome one of these events would have send MNKD near zero!
This factor is completly out now! Mannkind has won this war!
Shorties: No reason any longer to place a stop loss order, because the situation since friday has completly changed. MNKD has now everything under complete control. Not only $40 Mill coming from Deerfield - even a secondary offering would not create much dilution and gives Mannkind more power in negotiations - I can not see any pressure from outside - so we are to decide partnership. Acceptance of Afrezza has already been proved through 6.500 Patients in clinical trials - only very few Patients discontinued trial as a result institutional buying will begin now very heavily before the train has left the station.
Fact: 68 Mill shares are short (30% of float), although many of them are hedged with call options
Fact: 47 % shares owned by Insiders
Fact: 18 % shares held by Institutions
We can be sure that due to institutional interest pps driving higher, makes outstanding float much lower. We can also be sure that shorts will attack pps on monday again (picking all stop loss orders). I think, we will see an ugly monday with very, very nervous trading and several attacks.
But one thing is sure: pps will definitly drive much, much higher in the coming days, weeks, month and years!
No more possible event, which could hinder Afrezza's triumph!! Technosphere ? I'm so glad to own this stock! I will never sell shares in double digits other than a buyout - and both events are very soon possible!
regards
Kimi Less
. .
.
Back To Board
Wo sollten den die 69 Mio Shorts bei 39 Mio gehandelten Aktien gecovert haben, das es keinen squeeze mehr geben sollte ?
Die Margin calls werden kommen....die Meldung haben nur einige wenige am Freitagabend realisiert...das Gros der Broker wird sich erst am Montag positionieren!
Das die Zulassung-Meldung 20 Tage vor Ablauf am Freitag kurz vor Schluß kam, war für viele eine schaumige,kalte Dusche, vor der Bärenfellrasur!
Die Margin calls werden kommen....die Meldung haben nur einige wenige am Freitagabend realisiert...das Gros der Broker wird sich erst am Montag positionieren!
Das die Zulassung-Meldung 20 Tage vor Ablauf am Freitag kurz vor Schluß kam, war für viele eine schaumige,kalte Dusche, vor der Bärenfellrasur!
Warum???? Hat nicht ein Grossteil der shorts durch die Aktion nicht gecovert? Was soll eine Partnernewshier jetzt noch shorts grillen?
Das würde ich nicht sagen, daß kein squeeze mehr kommt, bei der richtigen Partnernews heißt`s: burn, shortie burn!
Mich hat es gewundert, warum nicht aufs WE gewartet wurde? So wurde es den Drecksäcken von Shirts leicht gemacht. Stecken vermutlich mit der FDA unter einer Decke. Ein squeeze wird nicht mehr kommen.....
Trading Spotlight
Antwort auf Beitrag Nr.: 47.227.698 von sunny3999 am 29.06.14 06:36:59Hi hi sehr gut!
Hier die genaue Beschreibung:
Storage
Not in Use: Refrigerated Storage 2-8ºC (36-46ºF)
Sealed (Unopened) Foil Package May be stored until the Expiration Date*
* If a foil package is not refrigerated, the contents must be used within 10 days.
In Use: Room Temperature Storage 25ºC (77ºF), excursions permitted 15-30ºC (59-86ºF)
Sealed (Unopened) Blister Cards + Strips Must be used within 10 days
Opened Strips Must be used within 3 days
Inhaler Storage:
Store at 2-25ºC (36-77ºF); excursions permitted. Inhaler may be stored refrigerated, but
should be at room temperature before use.
Handling:
Before use, cartridges should be at room temperature for 10 minutes.
http://www.mannkindcorp.com/collateral/documents/english-us/…
Storage
Not in Use: Refrigerated Storage 2-8ºC (36-46ºF)
Sealed (Unopened) Foil Package May be stored until the Expiration Date*
* If a foil package is not refrigerated, the contents must be used within 10 days.
In Use: Room Temperature Storage 25ºC (77ºF), excursions permitted 15-30ºC (59-86ºF)
Sealed (Unopened) Blister Cards + Strips Must be used within 10 days
Opened Strips Must be used within 3 days
Inhaler Storage:
Store at 2-25ºC (36-77ºF); excursions permitted. Inhaler may be stored refrigerated, but
should be at room temperature before use.
Handling:
Before use, cartridges should be at room temperature for 10 minutes.
http://www.mannkindcorp.com/collateral/documents/english-us/…
Zitat von Magnetfeldfredy: Das war dassselbe wie mit Dendreon damals, in 30 Sekunden haben die Drecksshorts den Kurs von US Dollar 15 auf ca. US Dollar 7 gedrückt um nachbörslich wieder bei 15 US Dollar zu stehen.
Die Wallstreet und deren Lakaien sind sowas von korrupt, daß einem das Kotzen kommt!
Aber für Mannkind jetzt egal, geschafft, Affrezza ist approved und steht vor einer rosigen Zukunft, weltweit immenser Bedarf, einzigartiges schnelles Wirkprofil, im Pfeifengroßen Inhalator ohne Spritzen, ohne Kühlung in heißen Länder.....ein Gamechanger eben!
Zur Kühlung gibt es leider eine kleine Änderung lt. Arzneimittelbeschreibung und Info von dereklinders:
Interesting that it must be kept refrigerated, with open foil packs only able to be unrefrigerated for 10 days & strips unrefrigerated for 3 days.
http://mannkind.freeforums.net/thread/708/pdf-label-afrezza?…
Das war dassselbe wie mit Dendreon damals, in 30 Sekunden haben die Drecksshorts den Kurs von US Dollar 15 auf ca. US Dollar 7 gedrückt um nachbörslich wieder bei 15 US Dollar zu stehen.
Die Wallstreet und deren Lakaien sind sowas von korrupt, daß einem das Kotzen kommt!
Aber für Mannkind jetzt egal, geschafft, Affrezza ist approved und steht vor einer rosigen Zukunft, weltweit immenser Bedarf, einzigartiges schnelles Wirkprofil, im Pfeifengroßen Inhalator ohne Spritzen, ohne Kühlung in heißen Länder.....ein Gamechanger eben!
Die Wallstreet und deren Lakaien sind sowas von korrupt, daß einem das Kotzen kommt!
Aber für Mannkind jetzt egal, geschafft, Affrezza ist approved und steht vor einer rosigen Zukunft, weltweit immenser Bedarf, einzigartiges schnelles Wirkprofil, im Pfeifengroßen Inhalator ohne Spritzen, ohne Kühlung in heißen Länder.....ein Gamechanger eben!
Ja habe ich auch gelesen, dafür gibt es aber keinen Beleg.
Durchsuchen
Mannkind, Game-Chancer in Sachen Diabetik?
